Cochrane Abstracts
Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phenobarbitone Versus Phenytoin Monotherapy for Epilepsy: an Individual Participant Data Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Phenobarbitone_versus_phenytoin_monotherapy_for_epilepsy:_an_individual_participant_data_review.
Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Phenobarbitone_versus_phenytoin_monotherapy_for_epilepsy:_an_individual_participant_data_review. Accessed January 14, 2025.
Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Phenobarbitone_versus_phenytoin_monotherapy_for_epilepsy:_an_individual_participant_data_review
Phenobarbitone Versus Phenytoin Monotherapy for Epilepsy: an Individual Participant Data Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Phenobarbitone_versus_phenytoin_monotherapy_for_epilepsy:_an_individual_participant_data_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
ID - 439919
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Phenobarbitone_versus_phenytoin_monotherapy_for_epilepsy:_an_individual_participant_data_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
